Get the Stockscreener App
7.25
1.36%
-0.10
After Hours:
7.25
Sage Therapeutics Inc Stock (SAGE) Forecast
The Sage Therapeutics Inc (SAGE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $63.69, representing a +778.54% increase from the current price of $7.25. The highest analyst price target is $62.82, and the lowest is $64.57.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SAGE Price Target
Average 67.35
(+829.01% Upside)
Is Sage Therapeutics Inc (SAGE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 61.60 | Neutral |
| STOCH(9,6) | 64.48 | Neutral |
| STOCHRSI(14) | 13.11 | Buy |
| MACD(12,26) | 0.3969 | Buy |
| ADX(14) | 26.56 | Buy |
| William %R | -53.85 | Neutral |
| CCI(14) | 3.6903 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.187
Buy
|
7.1599
Buy
|
| MA20 |
6.828
Buy
|
6.8476
Buy
|
| MA50 |
5.9766
Buy
|
6.4798
Buy
|
| MA100 |
6.4661
Buy
|
7.0398
Buy
|
| MA200 |
8.6939
Sell
|
9.6629
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, SAGE could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on SAGE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 61.6 indicates that SAGE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 64.48 indicates that SAGE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.11 indicates that SAGE is oversold. This suggests that SAGE price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.56 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 3.6903 indicates that SAGE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SAGE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sage Therapeutics Inc financial reports and earnings history, Sage Therapeutics Inc (SAGE) stock could reach $135.07 by 2030, $87.30 by 2040 and $338.77 by 2050. See the projected annual prices until 2050 of the Sage Therapeutics Inc stock below:
- Sage Therapeutics Inc (SAGE) is expected to reach an average price of $31.84 in 2035, with a high prediction of $36.35 and a low estimate of $32.48. This indicates an $339.13% rise from the last recorded price of $7.25.
- Sage Therapeutics Inc (SAGE) stock is projected to chart a bullish course in 2040, with an average price target of $77.14, representing an $963.99% surge from its current level. The forecast ranges from a conservative $79.62 to a sky-high $87.30.
- Our analysts predict Sage Therapeutics Inc (SAGE) to jump 2,545% by 2045, soaring from $192.86 to an average price of $191.76, potentially reaching $194.87. While $192.86 is the low estimate, the potential upside is significant.
- Sage Therapeutics Inc (SAGE) stock is expected to climb by 2050, reaching an average of $333.77, a $4,504% jump from its current level. However, a wide range of estimates exists, with high and low targets of $338.77 and $337.98, respectively, highlighting the market's uncertainty.
Sage Therapeutics Inc Stock (SAGE) Year by Year Forecast
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2025
Sage Therapeutics Inc Stock (SAGE) is expected to reach an average price of $72.58 in 2025, with a high prediction of $100.03 and a low estimate of $45.13. This indicates an +901.09% rise from the last recorded price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $85.17 | $64.57 | $62.82 | +1,075% |
| April, 2025 | $100.50 | $83.90 | $97.40 | +1,286% |
| May, 2025 | $92.61 | $96.49 | $100.03 | +1,177% |
| June, 2025 | $88.14 | $88.93 | $87.07 | +1,116% |
| July, 2025 | $82.26 | $88.06 | $86.47 | +1,035% |
| August, 2025 | $77.83 | $79.22 | $78.96 | +973.58% |
| September, 2025 | $68.13 | $73.56 | $74.47 | +839.77% |
| October, 2025 | $64.77 | $67.51 | $65.64 | +793.41% |
| November, 2025 | $53.39 | $55.36 | $57.82 | +636.43% |
| December, 2025 | $38.73 | $45.13 | $52.18 | +434.21% |
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2026
The predicted value for Sage Therapeutics Inc (SAGE) in 2026 is set at an average of $32.07. Estimates vary from a peak of $46.97 to a trough of $17.18, indicating an +342.39% surge from the present price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $34.62 | $34.68 | $33.92 | +377.51% |
| February, 2026 | $26.48 | $38.63 | $35.33 | +265.22% |
| March, 2026 | $14.97 | $17.18 | $18.29 | +106.45% |
| April, 2026 | $21.62 | $20.58 | $21.08 | +198.15% |
| May, 2026 | $25.34 | $25.55 | $21.78 | +249.45% |
| June, 2026 | $23.49 | $25.36 | $24.50 | +224.06% |
| July, 2026 | $26.84 | $22.86 | $21.39 | +270.25% |
| August, 2026 | $16.67 | $27.41 | $25.42 | +129.96% |
| September, 2026 | $38.65 | $38.20 | $37.38 | +433.12% |
| October, 2026 | $50.33 | $45.79 | $46.47 | +594.21% |
| November, 2026 | $43.33 | $45.34 | $46.97 | +497.64% |
| December, 2026 | $42.87 | $43.09 | $41.76 | +491.28% |
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sage Therapeutics Inc (SAGE) is $31.78, with a high forecast of $42.79 and a low forecast of $20.77. This indicates an +338.33% increase from the last price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $43.75 | $41.23 | $41.33 | +503.41% |
| February, 2027 | $42.40 | $42.39 | $42.79 | +484.78% |
| March, 2027 | $39.42 | $43.27 | $42.46 | +443.66% |
| April, 2027 | $36.04 | $38.16 | $37.00 | +397.16% |
| May, 2027 | $35.03 | $37.80 | $37.93 | +383.22% |
| June, 2027 | $40.72 | $34.90 | $38.89 | +461.68% |
| July, 2027 | $39.63 | $40.26 | $39.54 | +446.64% |
| August, 2027 | $37.86 | $36.45 | $35.37 | +422.21% |
| September, 2027 | $36.17 | $37.88 | $37.81 | +398.88% |
| October, 2027 | $32.63 | $32.52 | $35.60 | +350.04% |
| November, 2027 | $28.49 | $32.95 | $32.09 | +292.93% |
| December, 2027 | $19.18 | $20.77 | $27.93 | +164.50% |
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2028
In 2028, Sage Therapeutics Inc (SAGE) is projected to reach an average price of $11.86, with a high projection of $21.84 and a low estimate of $1.8934. This indicates an +63.65% rise from the last price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $21.60 | $20.07 | $20.63 | +197.86% |
| February, 2028 | $19.16 | $19.51 | $17.60 | +164.33% |
| March, 2028 | $18.26 | $18.37 | $18.03 | +151.90% |
| April, 2028 | $16.21 | $19.32 | $18.98 | +123.62% |
| May, 2028 | $13.15 | $13.09 | $12.35 | +81.39% |
| June, 2028 | $7.115 | $7.97 | $11.82 | -1.86% |
| July, 2028 | $2.7491 | $4.0191 | $4.2796 | -62.08% |
| August, 2028 | $5.798 | $4.8732 | $3.9584 | -20.03% |
| September, 2028 | $1.947 | $2.3173 | $1.1023 | -73.14% |
| October, 2028 | $7.5439 | $1.8934 | $8.5839 | +4.05% |
| November, 2028 | $10.71 | $7.8341 | $14.42 | +47.66% |
| December, 2028 | $9.826 | $8.871 | $21.84 | +35.53% |
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2029
The 2029 price forecast for Sage Therapeutics Inc Stock (SAGE) is $67.53 on average, with a high prediction of $134.61 and a low estimate of $0.4475. This represents an +831.43% increase from the previous price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1129 | $1.0931 | $13.51 | -98.44% |
| February, 2029 | $12.94 | $0.7826 | $12.49 | +78.51% |
| March, 2029 | $9.931 | $10.42 | $11.94 | +36.98% |
| April, 2029 | $9.4501 | $10.04 | $9.4108 | +30.35% |
| May, 2029 | $9.5289 | $8.5092 | $8.7594 | +31.43% |
| June, 2029 | $4.318 | $5.858 | $6.2687 | -40.44% |
| July, 2029 | $1.1171 | $1.1471 | $3.0078 | -84.59% |
| August, 2029 | $5.2541 | $0.7766 | $6.8088 | -27.53% |
| September, 2029 | $3.545 | $2.855 | $8.4448 | -51.10% |
| October, 2029 | $3.1562 | $2.7962 | $5.6359 | -56.47% |
| November, 2029 | $0.8129 | $0.6568 | $3.9314 | -88.79% |
| December, 2029 | $140.13 | $0.4475 | $134.61 | +1,833% |
Sage Therapeutics Inc Stock (SAGE) Price Forecast for 2030
Sage Therapeutics Inc Stock (SAGE) is expected to reach an average price of $173.17 in 2030, with a high forecast of $228.47 and a low forecast of $117.88. This signifies an +2,289% surge from the last price of $7.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $127.33 | $133.63 | $135.07 | +1,656% |
| February, 2030 | $108.05 | $123.23 | $115.75 | +1,390% |
| March, 2030 | $133.53 | $117.88 | $128.80 | +1,742% |
| April, 2030 | $119.72 | $126.79 | $123.35 | +1,551% |
| May, 2030 | $145.39 | $131.31 | $143.27 | +1,905% |
| June, 2030 | $135.79 | $143.26 | $141.27 | +1,773% |
| July, 2030 | $128.42 | $131.40 | $133.71 | +1,671% |
| August, 2030 | $198.00 | $126.98 | $197.67 | +2,631% |
| September, 2030 | $192.14 | $197.09 | $197.97 | +2,550% |
| October, 2030 | $196.50 | $194.48 | $197.23 | +2,610% |
| November, 2030 | $223.79 | $196.37 | $212.94 | +2,987% |
| December, 2030 | $230.96 | $229.65 | $228.47 | +3,086% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):